Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib
Hughes, Timothy P., Lipton, Jeffrey H., Spector, Nelson, Cervantes, Francisco, Pasquini, Ricardo, Clementino, Nelma Cristina D., Dorlhiac Llacer, Pedro Enrique, Schwarer, Anthony P., Mahon, Francois-Xavier, Rea, Delphine, Branford, Susan, Purkayastha, Das, Collins, LaTonya, Szczudlo, Tomasz, Leber, Brian
Published in Blood (31.07.2014)
Published in Blood (31.07.2014)
Get full text
Journal Article
RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis
Cosgriff, Thomas, Yang, Lin, Alyasova, Anna, Ye, Dingwei, Karpenko, Andrey, Li, Hanzhong, Alekseev, Boris, Xie, Li-ping, Kowalyszyn, Ruben Dario, Karyakin, Oleg, Neron, Yeni Verónica, Collins, LaTonya, Brechenmacher, Thomas, Lin, Chinjune, Morgan, Liza, Motzer, Robert J.
Published in Journal of clinical oncology (10.01.2016)
Published in Journal of clinical oncology (10.01.2016)
Get full text
Journal Article
RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis
Cosgriff, Thomas, Yang, Lin, Alyasova, Anna, Ye, Dingwei, Karpenko, Andrey, Li, Hanzhong, Alekseev, Boris, Xie, Li-ping, Kowalyszyn, Ruben Dario, Karyakin, Oleg, Neron, Yeni Verónica, Collins, LaTonya, Brechenmacher, Thomas, Lin, Chinjune, Morgan, Liza, Motzer, Robert J.
Published in Journal of clinical oncology (10.01.2016)
Published in Journal of clinical oncology (10.01.2016)
Get full text
Journal Article
RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC)
Motzer, Robert, Alyasova, Anna, Ye, Dingwei, Karpenko, Andrey, Li, Hanzhong, Alekseev, Boris Y., Xie, Liping, Kurteva, Galina Petrova, Kowalyszyn, Ruben Dario, Neron, Yeni, Cosgriff, Thomas, Collins, LaTonya, Brechenmacher, Thomas, Segal, Scott, Morgan, Liza M., Yang, Lin
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Effect of continued imatinib (IM) in pts with detectable BCR-ABL after ≥ 2 years on study on deep molecular responses (MR): 36-month update from ENESTcmr
Spector, Nelson, Clementino, Nelma Cristina D., Dorlhiac-Llacer, Pedro Enrique, Leber, Brian, Hughes, Timothy P., Cervantes, Francisco, Schwarer, Anthony P., Forrest, Donna L., Kamel-Reid, Suzanne, Bendit, Israel, Acharya, Sandip, Collins, LaTonya, Dalal, Darshan, Lipton, Jeffrey H.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Achievement and Maintenance Of Deeper Molecular Response By Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Residual Disease On Long-Term Imatinib: ENESTcmr 36-Month Follow-Up
Leber, Brian, Cervantes, Francisco, Spector, Nelson, Lipton, Jeffrey H., Etienne, Gabriel, Pasquini, Ricardo, Clementino, Nelma Christina, Guerci-Bresler, Agnès, Forrest, Donna, Schwarer, Anthony P., Acharya, Sandip, Collins, LaTonya, Szczudlo, Tomasz, Hughes, Timothy P.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Switching patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) with residual disease on long-term imatinib (IM) to nilotinib (NIL): ENESTcmr 24-mo follow-up
Spector, Nelson, Leber, Brian, Lipton, Jeffrey Howard, De Souza, Carmino, Moiraghi, Beatriz, Steegmann, Juan Luis, Schwarer, Anthony P., Cervantes, Francisco, Hughes, Timothy P., Purkayastha, Das, Collins, LaTonya R, Szczudlo, Tomasz K., Rea, Delphine
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Survey of the Frontline Treatment and Management of Chronic Myeloid Leukemia (CML) in a Real-Word Setting: The 3rd Annual Update of the Worldwide Observational Registry Collecting Longitudinal Data on Management of Chronic Myeloid Leukemia Patients (The WORLD CML Registry)
Pasquini, Ricardo, Cortes, Jorge E., Kantarjian, Hagop M., Joske, David, Meillon, Luis A, Zernovak, Oleg, Sivarathinasami, Ramsathish, Collins, LaTonya, Hughes, Timothy P., Kim, Dong-Wook
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Switching to Nilotinib Is Associated with Continued Deeper Molecular Responses in CML-CP Patients with Minimal Residual Disease After ≥ 2 Years On Imatinib: Enestcmr 2-Year Follow-up Results
Hughes, Timothy P., Lipton, Jeffrey H., Spector, Nelson, Leber, Brian, Pasquini, Ricardo, Clementino, Nelma, Schwarer, Anthony P., Etienne, Gabriel, Guerci-Bresler, Agnès, Branford, Susan, Purkayastha, Das, Collins, LaTonya, Szczudlo, Tomasz, Cervantes, Francisco
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Switch to nilotinib versus continued imatinib in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) with detectable BCR-ABL after 2 or more years on imatinib: ENESTcmr 12-month (mo) follow-up
Lipton, Jeffrey Howard, Hughes, Timothy P., Leber, Brian, De Souza, Carmino, Dorlhiac-Llacer, Pedro E, Steegmann, Juan Luis, Guerci-Bresler, Agnes, Schwarer, Anthony P., Cervantes, Francisco, Reynolds, John, Collins, LaTonya R, Szczudlo, Tomasz K., Spector, Nelson
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A Phase III, Randomized, Open-Label Study of 400 Mg Versus 800 Mg of Imatinib Mesylate (IM) in Patients (pts) with Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Using Molecular Endpoints: 1-Year Results of TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) Study
Cortes, Jorge, Baccarani, Michele, Guilhot, François, Druker, Brian J., Branford, Susan, Kim, Dong-Wook, Pane, Fabrizio, Rudoltz, Marc, Yu, Richard, Collins, LaTonya, Krahnke, Tillmann, Radich, Jerald P., Hughes, Timothy P
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
GPS Wing At LA Air Force Base Changes Command
LaTonya Lofton-Collins for Global Positioning Systems Wing
Published in UPI Space Daily (22.06.2007)
Get full text
Published in UPI Space Daily (22.06.2007)
Newsletter